Humoral response against myelin antigens in two strains of rats with different susceptibility to experimental allergic encephalomyelitis (EAE)

Autoimmunity

Volumn 29, Issue 2, 1999, Pages 129-137

  Rivero, Virginia E ^a   Riera, Clelia M ^a   Roth, German A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Autoantibodies; Experimental allergic encephalomyelitis; Myelin basic protein; Rat strains; Susceptibility

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; MYELIN; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; DISEASE PREDISPOSITION; DISEASE RESISTANCE; FEMALE; HUMORAL IMMUNITY; IMMUNOBLOTTING; MALE; NONHUMAN; RAT;

EID: 0032906901     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908995382     Document Type: Article

References (46)

1. Maggio, B., Cumar, F.A., Roth, G.A., Monferrán, C.G. and Fidelio, G.D. Neurochemical and model membrane studies in demyelinating diseases. Acta Neuropathol. (Berlin) 1983; 9(Suppl): 71-85.
2. Raine, C.S. Experimental allergic encephalomyelitis and experimental allergic neuritis. Handb. Clin. Neurol. 1985; 47: 429-466.
3. Tabira, T. Autoimmune demyelination in the central nervous system. Ann. NY Acad. Sci. 1988; 540: 187-201.
4. Hughes, R.A.C. and Stedronska, J. The susceptibility of rat strains to experimental allergic encephalomyelitis. Immunology 1973; 24: 879-884.
5. Roth, G.A. and Obata, K. Experimental allergic encephalomyelitis: Dissociation of immunochemical and clinicopathological responses in two strains of rats. Neurochem. Int. 1991; 19: 213-220.
6. Encinas, J.A., Weiner, H.L. and Kuchroo, V.K. Inheritance of susceptibility to experimental autoimmune encephalomyelitis. J. Neurosci. Res. 1996; 45: 655-669.
7. de Brito, F.B. and Hanahoe, T.H.P. Susceptibility of two colonies of Wistar rats to inflammation, with particular reference to delayed hypersensitivity. Int. Archs. Allergy Appl. Immun. 1983; 72: 164-169.
8. Tabira, T. and Kira, J.-I. Strain and species differences of encephalitogenic determinants of myelin basic protein and proteolipid apoprotein. In: Martenson, R.E. (ed.). Myelin: Biology and Chemistry. Boca Raton, FL: CRC Press, 1992; pp. 783-800.
9. Happ, M.P., Wettstein, P., Dietzschold, B. and HeberKatz, E. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects. J. Immunol. 1988; 141: 1489-1494.
10. Fugger, L., Liang, J., Gautam, A., Rothbard, J.B. and Mcdevitt, H.O. Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-A (U), which confers susceptibility to experimental allergic encephalomyelitis. Mol. Med. 1996; 2: 181-188.
11. Sternberg, E.M., Hill, J.M., Chrousos, G.P., Kamilaris, T., Listwak, S.J., Gold, P.W. and Wilder, R.L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Nail. Acad. Sci. USA 1989; 86: 2374-2378.
12. Hashim, G.A. and Day, E.D. Role of antibodies in T cell-mediated experimental allergic encephalomyelitis. J. Neurosci. Res. 1988; 21: 1-5.
13. + T-suppressor cells and myelin basic-primed B cells. J. Neuroimmunol. 1991; 33: 173-177.
14. Willenborg, D.O., Sjollema, P. and Danta, G. Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis. J. Neuroimmunol. 1986; 11: 93-103.
15. Myers, K.J., Sprent, J., Dougherty, J.P. and Ron, Y. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 1992; 41: 1-8.
16. Wolf, S.D., Dittle, B.N., Hardardottir, F. and Janeway, C.A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 1996; 184: 2271-2278.
17. McFarlin, D.E., Hsu, S.C., Slemenda, S.B., Chou, F.C. and Kibler, R.F. The immune response against myelin basic protein in two strains of rat with different genetic capacity to develop experimental allergic encephalomyelitis. J. Exp. Med. 1975; 141: 72-81.
18. Roth, G.A., Yu, R.K. and Bornstein, M.B. Chemical analysis of organotypic cultures of mouse spinal cord in normal, demyelinative, and nondemyelinative conditions. J. Neurochem. 1983; 41: 1710-1717.
19. Nishizawa, M., Tanaka, M., Inizuka, T., Tanaka, K., Baba, H., Miyatami, N., Sato, S. and Miyatake, T. Production and characterization of monoclonal antibodies against myelin-associated glycoprotein. J. Neurochem. 1986; 47: 1893-1900.
20. Rivero, V.E., Maccioni, M., Bucher, A.E., Roth, G.A. and Riera, C.M. Suppression of experimental autoimmune encephalomyelitis (EAE) by intraperitoneal administration of soluble myelin antigens in Wistar rats. J. Neuroimmunol. 1997; 72: 3-10.
21. Lando, Z., Teitelbaum, D. and Arnon, R. Induction of EAE in genetically resistant strains of mice. Nature 1980; 287: 551-552.
22. Beraud, E., Reshef, T., Vandenbark, A.A., Offner, H., Friz, R., Chou, C.-H.J., Bernard, D. and Cohen, I.R. Experimental autoimmune encephalomyelitis mediated by T lymphocyte lines: genotype of antigen-presenting cells influences immuno dominant epitope of basic protein. J. Immunol. 1986; 136: 511-515,
23. Trotter, J., Zamvill, A.A. and Steinman, L. Comparison of antigen specificity, class II major histocompatibility complex restriction and in vivo behavior of myelin basic protein-specific T cell lines and clones derived from (BALB/c × SJL/J) mice. J. Immunol. 1987; 139: 1834-1839.
24. Abromson-Leeman, S., Hayashi, M., Martin, C., Sobel, R., Al-Sabbagh, A., Weiner, H. and Dorf, M.E. T cell response to myelin basic protein in experimental autoimmune encephalomyelitis-resistant BALB/c mice. J. Neuroimmunol. 1993; 45: 89-96.
25. Mustafa, M., Vingsbo, C., Olsson, T., Issazadeh, S., Ljungdahl, A. and Holmdahl, R. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and Class II alleles. J. Immunol. 1994; 153: 3337-3344.
26. Issazadeh, S., Kjellen, P., Olsson, T., Mustafa, M. and Holmdahl. R. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific. Eur. J. Immunol. 1997; 27: 1584-1587.
27. Mostarica-Stojkovic, M., Petrovic, M. and Lukic, M.L. Resistance to the induction of EAE in AO rats: its prevention by the pre-treatment with cyclophosphamide or low dose of irradiation. Clin. Exp. Immunol. 1982; 50: 311-317.
28. Abromson-Leeman, S., Alexander, J., Bronson, R., Carroll, J., Southwood, S. and Dorf, M.E. Experimental allergic encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II. J. Immunol. 1995; 154: 388-398.
29. Shaw, M.K , Kim, C., Ho, K.H., Lisak, R.P. and Tse, H.Y. A combination of adoptive transfer and antigenic challenge induces consistent murine autoimmune encephalomyelitis in C57BL/6 mice and other reputed resistant strains. J. Neuroimmunol 1992; 39: 139-150.
30. Levine, S. and Sowinski, R. Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats. J. Immunol. 1975; 114: 597-601.
31. Saudi, A., Kuhn, J., Huygen, K., De Kozak, Y., Velu, T., Goldman, M., Druet, P. and Bellon, B. Th2 activated cells prevent experimental autoimmune uveoretinitis, a Th1-dependant autoimmune disease. Eur. J. Immunol. 1993; 23: 3096-3103.
32. Der Balian, G.P., Slack, J., Clevinger, B.L., Bazin, H. and Davie, J.M. Subclass restriction of murine antibodies. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats. J. Exp. Med. 1980; 152: 209-218.
33. Sayavey, M.H., Akalin, E., Hancok, W.W., Russel, M.E., Carpenter, C.B., Linsley, P.S. and Turka, L.A. CD 28-B7 blockade after allogenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 1995; 181: 1869-1874.
34. Smith, L.A. and Rumanjanek, V.M. Transfer of protection against allergic encephalomyelitis from mother to offspring. Immunology 1984; 51: 201-204.
35. MacPhee, I.A., Day, M.J. and Mason, D.W. The role of serum factors in the suppression of EAE evidence for immunoregulation by antibody to encephalitogenic peptide. Immunology 1990; 70: 527-534.
36. Rott, O., Bernard, F. and Cash, E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 1994; 24: 1434-1440.
37. Bach, J.-F. Organ-specific autoimmunity. Immunol. Today 1995; 16: 353-355.
38. Kumar, V. and Sercarz, E. Dysregulation of potentially pathogenic self reactivity is crucial for the manifestation of clinical autoimmunity. J. Neurosci. Res. 1996; 45: 334-339.
39. Slattery, R.M., Miller, J.F.A.P., Heath, W.R. and Charlton, B. Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 1993; 90: 10808-10810.
40. Wen, L., Roberts, S.J., Viney, J.L., Wong, .S., Mallick, C., Findly, R.C., Peng, Q., Craft, J.E., Owen, M.J. and Hayday, A.C. Immunoglobulin synthesis and generalized autoimF munity in mice congenitally deficient in αβ(+) T cells. Nature 1994; 369: 654-658.
41. Ando, D.G., Clayton, J., Kono, D., Urban, J.L. and Sercarz, E. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of ThI lymphokine subtype. Cell Immunol 1989; 124: 132-143.
42. Racke, M.K., Bonomo, A., Scott, D.E., Cannella, B., Levine, A., Raine, C.S., Shevach, E.M. and Röcken, M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 1994; 180: 1961-1966.
43. Karpus, W.J., Gould, K.E. and Swanborg, R.H. CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur. J. Neurosci. 1992; 22: 1757-1763.
44. Khoury, S.J., Hancock, W.W. and Weiner, H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differ-ential upregulation of transforming growth factor β, interleukin-4 and prostaglandin E in the brain. J. Exp. Med. 1992; 176: 1355-1364.
45. Leonard, J.P., Waldburger, K.E. and Goldman, S.J. Prevention of experimental autoimmune encephalomyelitis by antibodies against Interleukin 12. J. Exp. Med. 1995; 181: 381-386.
46. Kelso, A. Th1 and Th2 subsets: paradigms lost? Immunol. Today 1995; 16: 374-379.